We also found that the down-regulated pathways affected by CD163 included antigen processing and presentation, autoimmune thyroid disease, graft versus host disease, and intestinal pathways immune network for IGA production and type I diabetes mellitus (Figure 7A). Here, CD163 is linked to autoimmune thyroid disease.